4//SEC Filing
Dudley Robert Michael 4
Accession 0001104659-22-100931
CIK 0001829635other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:44 PM ET
Size
5.1 KB
Accession
0001104659-22-100931
Insider Transaction Report
Form 4
Dudley Robert Michael
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2022-09-14$1.15/sh+20,000$23,000→ 893,114 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.1761, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001854161
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:44 PM ET
- Size
- 5.1 KB